Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vivani Medical Inc (VANI)

Vivani Medical Inc (VANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 91,263
  • Shares Outstanding, K 54,978
  • Annual Sales, $ 0 K
  • Annual Income, $ -25,650 K
  • 60-Month Beta 3.26
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.01
Trade VANI with:

Options Overview Details

View History
  • Implied Volatility 141.20% ( +0.12%)
  • Historical Volatility 63.18%
  • IV Percentile 10%
  • IV Rank 4.86%
  • IV High 1,080.57% on 09/25/23
  • IV Low 93.23% on 03/25/24
  • Put/Call Vol Ratio 15.00
  • Today's Volume 192
  • Volume Avg (30-Day) 127
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 3,498
  • Open Int (30-Day) 4,653

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6100 +6.83%
on 04/30/24
2.2200 -22.52%
on 04/08/24
-0.1600 (-8.51%)
since 04/02/24
3-Month
1.0100 +70.30%
on 02/27/24
7.8000 -77.95%
on 02/28/24
+0.6900 (+66.99%)
since 02/02/24
52-Week
0.8400 +104.76%
on 12/21/23
7.8000 -77.95%
on 02/28/24
+0.3500 (+25.55%)
since 05/02/23

Most Recent Stories

More News
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study

Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company received...

VANI : 1.7200 (+3.61%)
Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment...

VANI : 1.7200 (+3.61%)
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, today announced the...

VANI : 1.7200 (+3.61%)
Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including lead asset NPM-119 for the treatment of patients...

VANI : 1.7200 (+3.61%)
Vivani Medical to Present at the ThinkEquity Investor Conference

Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, announced today that...

VANI : 1.7200 (+3.61%)
Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

Vivani Medical, Inc., formerly Second Sight Medical, Inc., (NASDAQ: VANI) (the “Company” or “Vivani”) announced that trading of the Company’s common stock on The Nasdaq Capital Market under the...

EYES : 4.14 (-5.05%)
VANI : 1.7200 (+3.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second...

See More

Key Turning Points

3rd Resistance Point 1.8725
2nd Resistance Point 1.8063
1st Resistance Point 1.7631
Last Price 1.7200
1st Support Level 1.6537
2nd Support Level 1.5875
3rd Support Level 1.5443

See More

52-Week High 7.8000
Fibonacci 61.8% 5.1413
Fibonacci 50% 4.3200
Fibonacci 38.2% 3.4987
Last Price 1.7200
52-Week Low 0.8400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar